Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Sarcoma, Alveolar Soft Part

• A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
• Testing Atezolizumab With or Without Selinexor in Patients >= 18 Years Old With Alveolar Soft Part Sarcoma
• A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
• Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
• Testing Atezolizumab and Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
• Testing Atezolizumab and Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
• Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
• A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
• Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
• Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
• Pazopanib for Metastatic Alveolar Soft Part Sarcoma
• Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
• Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
• CREATE: Cross-tumoral Phase 2 With Crizotinib
• Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
• A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)
• Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
• Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
• Phase 2 Study in Patients With MiT Tumors
• Trial of Dasatinib in Advanced Sarcomas
• A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
• Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma